Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

VHTvsFTXHETF Comparison

ETF 1
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
-0.12%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-0.12%

Vanguard Health Care ETF (VHT) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. VHT's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, FTXH's top sector exposures are Healthcare. VHT is less expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.6% for FTXH. VHT is up 8.8% year-to-date (YTD) with +$98M in YTD flows. FTXH performs better with 23.32% YTD performance, and +$978M in YTD flows. Run a side-by-side ETF comparison of VHT and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

VHT vs FTXH performance and flow charts

Performance

-2.00.02.04.06.0%Aug 10Aug 17Aug 24Aug 31Sep 8

Cumulative Flows

0 M20 M40 M60 M80 MAug 10Aug 17Aug 24Aug 31Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/11/2026
1M3MYTD1Y3Y5Y
Perf.
VHT
FTXH
-1.57%+0.75%
+8.74%+14.81%
+8.80%+23.32%
+21.61%+46.70%
+33.62%+58.20%
+30.16%+66.91%
Flows
VHT
FTXH
+$81M+$41M
+$351M+$968M
+$98M+$978M
+$351M+$981M
-$2.17B+$973M
-$958M+$977M
Volatility and drawdown
3M1Y3Y5Y
Volatility
VHT
FTXH
+18.13%+20.07%
+15.65%+17.74%
+14.65%+16.99%
+15.57%+16.34%
Max drawdown
VHT
FTXH
-5.63%-5.34%
-10.39%-7.50%
-16.88%-19.32%
-17.77%-19.32%
Max drawdown duration
VHT
FTXH
23d16d
169d99d
435d393d
767d393d
Trading data

Create an account to view trading data

Join for free
VHT
FTXH
Last sale
9/11/2026 at 1:30 PM
$310.74
$40.47
Previous close
09/10/2026
$311.27
$40.52
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
VHT
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
VHT
FTXH
Last price
$310.74
$40.47
1D performance
-0.17%
-0.13%
AuM$18.79 B$1.04 B
E/R0.09%0.6%
Characteristics
VHT
FTXH
Management strategyPassivePassive
ProviderVanguardFirst Trust
BenchmarkMSCI US IMI Health Care 25/50 IndexNASDAQ US Smart Pharmaceuticals Index
N° of holdings41349
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2004September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

VHT
USA
96.91%
Other
3.09%
FTXH
USA
95.79%
Other
4.21%

Sectors

VHT
Healthcare
97.52%
Other
2.48%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement

Diversification

VHT

Total weight of top 15 holdings out of 15

61.16%
FTXH

Total weight of top 15 holdings out of 15

66.98%

Top 15 holdings

Data as of July 31, 2026
VHT
Eli Lilly & Co.
13.37%
Johnson & Johnson
8.83%
AbbVie, Inc.
6.43%
UnitedHealth Group, Inc.
5.45%
Merck & Co., Inc.
4.67%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
3.01%
Abbott Laboratories
2.67%
Gilead Sciences, Inc.
2.34%
Pfizer Inc.
2.06%
Bristol Myers Squibb Co.
1.93%
CVS Health Corp.
1.93%
Intuitive Surgical, Inc.
1.82%
Danaher Corp.
1.80%
Vertex Pharmaceuticals, Inc.
1.76%
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
Frequently asked questions about VHT and FTXH

How have the VHT and FTXH ETFs performed in 2026?

As of September 11, 2026, VHT is up 8.8% year-to-date (YTD), while FTXH has returned 23.32%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: VHT or FTXH?

Year-to-date, the VHT ETF saw +$98M in flows, compared to +$978M for FTXH.

Which ETF is more volatile: VHT or FTXH?

Over the past year, VHT had a volatility of 15.65%, while FTXH experienced 17.74%.

Which ETF is bigger: VHT or FTXH?

As of September 11, 2026, VHT holds $18.79 B in assets under management (AUM), while FTXH manages $1.04 B.

What sectors do the VHT and FTXH ETFs invest in?

VHT leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the VHT ETF and FTXH ETF?

VHT top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FTXH holds in its top three: Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc..

Which ETF is more diversified: VHT or FTXH?

VHT holds 413 securities with 61.16% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 66.98%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder